The implementation of screening for prostate cancer
- 3 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 13 (3), 218-227
- https://doi.org/10.1038/pcan.2010.14
Abstract
The objective of this study was to determine whether screening for prostate cancer (PC) reduces PC mortality and, if so, whether the required criteria to be introduced as a population-based screening program are satisfied. A literature review was conducted through electronic scientific databases. The screening tests, that is, PSA and digital rectal examination, have limited sensitivity and specificity for detecting PC; screening produces a beneficial stage shift and reduces PC mortality. Nevertheless, PC screening causes a large increase in the cumulative incidence, and the understanding of the economic cost and quality-of-life parameters are limited. PC screening cannot be justified yet in the context of a public health policy. Prostate Cancer and Prostatic Diseases (2010) 13, 218-227; doi:10.1038/pcan.2010.14; published online 3 August 2010Keywords
This publication has 74 references indexed in Scilit:
- Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefitEuropean Journal Of Cancer, 2010
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological studyThe Lancet Oncology, 2008
- Does the Level of Prostate Cancer Risk Affect Cancer Prevention with Finasteride?Urology, 2008
- Estimates of the cancer incidence and mortality in Europe in 2006Annals Of Oncology, 2007
- A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural IndiaInternational Journal of Cancer, 2005
- The Finnish trial of prostate cancer screening: where are we now?BJU International, 2003
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMESThe Lancet, 1987